Premature for Life
Arch Ophthalmol. 2005;123:392-394.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
In 1988, the ARCHIVES published the preliminary findings of the Multicenter Trial of Cryotherapy for Retinopathy of Prematurity (CRYO-ROP Study).1 Even 16 years later, I vividly recall the tremendous excitement generated by that report, for after more than 20 years of uncertainty, here at last was an effective treatment for one of the major causes of childhood blindness. This issue of the ARCHIVES contains the final results2 from the CRYO-ROP Study, which report the outcomes of those babies who were randomized to treatment in the 1980s and who are now teenagers at 15 years of age. This marks the end of the line for the CRYO-ROP Study so now is the obvious time to glance back to review the impact of this study and see whether the hope to reduce retinopathy of prematurity (ROP) blindness has been realized in the long-term. With reports of outcome at 1, 3.5, . . . [Full Text of this Article]
AUTHOR INFORMATION
Alistair R. Fielder, FRCP, FRCOphth
RELATED LETTERS
We Can Aim at Better Results in Coming Years
Subhadra Jalali and Anjli Hussain
Arch Ophthalmol. 2006;124(4):604-605.
EXTRACT
| FULL TEXT
We Can Aim at Better Results in Coming Years—Reply
Earl A. Palmer
Arch Ophthalmol. 2006;124(4):605-606.
EXTRACT
| FULL TEXT
RELATED ARTICLE
15-Year Outcomes Following Threshold Retinopathy of Prematurity: Final Results From the Multicenter Trial of Cryotherapy for Retinopathy of Prematurity
Cryotherapy for Retinopathy of Prematurity Cooperative Group
Arch Ophthalmol. 2005;123(3):311-318.
ABSTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
We can aim at better results in coming years.
Jalali and Hussain
Arch Ophthalmol 2006;124:604-605.
FULL TEXT
|
